CUTR stock trades on Cutera debt and loss metrics

Cutera Inc. (US2321471000) remains a numbers-first name for CUTR stock, with the latest available report showing revenue of $65.8 million for fiscal 2024, down 37.5% from $105.3 million in fiscal 2023. The same filing also showed a net loss of $235.6 million in fiscal 2024, while long-term debt stood at $312.1 million at year-end 2024.

Revenue fell 37.5%

The 37.5% revenue decline from fiscal 2023 to fiscal 2024 is the clearest operational marker in the current setup, and it came alongside a much larger loss base. That combination matters because it leaves CUTR stock dependent on margin repair, cash preservation, and debt management rather than simple top-line growth.

In the latest annual context, the company also reported gross profit of $37.6 million for fiscal 2024 versus $62.1 million in fiscal 2023, showing how the weaker sales line flowed through the income statement. The gap between revenue and profitability remains wide.

Debt still dominates

Long-term debt of $312.1 million at 31 December 2024 is a second hard anchor for the share story, because it sits against a much smaller revenue base of $65.8 million for the full year. In practical terms, the balance sheet carries more weight than short-term product momentum.

The loss figure of $235.6 million in fiscal 2024 also gives the market a clear comparison point against fiscal 2023, when the company reported a net loss of $159.9 million. That wider loss is the kind of quantified change that keeps valuation tied to financing risk and operating recovery.

Latest report matters

The most useful interpretation for investors is that CUTR stock is still trading on the latest report cycle rather than on a single product headline. Revenue, gross profit, loss, and debt now define the near-term framework more clearly than any broad business description.

Because the company has already published the 2024 annual numbers, the key read-through is whether future quarters can narrow the $235.6 million loss and lift revenue back above the $65.8 million annual level. Until that happens, the financial profile remains the central market variable.

Laser systems stay central

Cutera Inc. sells aesthetic and dermatology systems, and that product base still matters because recurring demand and installed-base usage feed the reported revenue line. In fiscal 2024, however, the business was still working through the impact of a much smaller top line than the prior year.

The company therefore reads less like a pure product story and more like a restructuring-and-recovery case. The operating question is whether system sales and consumables can lift the revenue base enough to close the gap between $65.8 million revenue and $312.1 million debt.

Market value frame

The stock-focused frame here is straightforward: the latest evidenced market context is still anchored in the fiscal 2024 results, which are the numbers most likely to shape valuation until a newer filing changes the picture. For CUTR stock, the comparison between $65.8 million revenue, $235.6 million net loss, and $312.1 million debt is the core triad.

That triad is enough to explain why the share story remains sensitive to every new report cycle. The annual figures are dated, quantified, and comparable, which is the right base for reading the name today.